Home Press Release Pharmaceutical Rd Outsourcing Market Size Projected to Reach $180 billion by 2034 | 8.4%

Pharmaceutical Rd Outsourcing Market Size Projected to Reach $180 billion by 2034 | 8.4%

23 Jul, 2026

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “Pharmaceutical R&D Outsourcing Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to Straits Research, the global pharmaceutical R&D outsourcing market size was valued at $85 billion in 2025 and is projected to grow from $93 billion in 2026 to $180 billion by 2034, registering a CAGR of 8.4% during the forecast period 2026–2034.

The pharmaceutical R&D outsourcing market is segmented based on development stage, company size, and region. Some of the insights provided in the report are highlighted below:

  • The non-clinical segment is expected to register a CAGR of 6.8% during the forecast period.
  • North America is expected to lead the market during the forecast period, owing to clear regulatory pathways and the presence of well-established players.
  • Sponsors increasingly rely on CROs in emerging markets for cost optimization and access to large patient populations.
  • Germany is the leading country in the Europe market due to advanced research infrastructure and robust quality standards.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

By Development Stage

  • Clinical
  • Non-clinical

By Company Size

  • Small and Mid-sized Companies
  • Large Companies

By Region

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East & Africa